Regulatory Articles

Japan conditionally approves stem cell treatments for Parkinson’s and heart failure. Clinical trials show significant functional recovery, shifting from managing symptoms to restoring health.

Wyoming’s Senate File 48, the Stem Cell Freedom Act, proposes a legal framework for physicians to perform autologous stem cell therapies under IRB oversight and cGMP safety standards.

New laws are being proposed to make it easier for you to use your own stem cells for healing. This means you could access new treatments for injuries or pain much faster, using your body's own repair cells to help you get well.

Something important changed in Florida on July 1: the state passed a law (Senate Bill SB‑1768) that allows licensed physicians to offer certain stem cell treatments that are not yet FDA-approved — but only for specific uses (orthopedics, wound care, and pain management) and only if strict rules a...

New Hampshire House Bill 701 establishes the Terminal Patients' Right to Try Act, providing legal pathways for terminally ill patients to access experimental treatments including regenerative therapies.

The Federation of State Medical Boards provides comprehensive guidelines for regenerative therapy practices, establishing standards for physician training, patient safety, and regulatory compliance across state medical boards.

Utah Senate Bill SB0199 introduces amendments to existing regulations regarding placental tissue use in medical treatments, clarifying legal frameworks for regenerative medicine applications.

Montana Legislative Bill LC0780/SB535 establishes frameworks for experimental treatment centers, providing pathways for innovative medical treatments including regenerative therapies under controlled conditions.

Florida HB 1617 authorizes physicians to perform FDA-unapproved stem cell therapy with specific requirements for manufacturing practices, patient consent, and advertising disclosures. Effective July 1, 2025.